FranΓ§aisπ See the interactive version (live chart) β
For Cognex, we replayed every analyst price target of the past 12 months and measured the real outcome: 34% were profitable, average return +1% (94 calls). At 3 months: -1% average return (36% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Needham | 19 | 26% | +8% |
| Raymond James | 11 | 27% | +7% |
| Morgan Stanley | 11 | 54% | -2% |
| Goldman Sachs | 10 | 30% | -31% |
| CLSA | 5 | 60% | +6% |
Is Cognex overvalued, and is it a good time to buy Cognex right now? If you're wondering, here's a recap to make up your own mind: Cognex's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Cognex | Sector median (Information Technology) |
|---|---|---|
| P/E | 59.4 | 39.4 |
| Forward P/E | 31.1 | 20.6 |
| Net margin | 16% | 16% |
π Cognex trades above its sector median (59.4 vs 39.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Cognex pays about $0.34/share/yr β 0.47% yield. what is this?
The analyst consensus on Cognex (CGNX) is "Buy" (19 bullish, 2 bearish calls over 12 months). This is not advice: historically, 34% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $78.00 (+24% vs $62.97), ranging from $65.00 to $84.00 (9 analysts).
Over 1 year, 34% of analyst targets on Cognex were profitable, for an average return of +1% (across 94 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $78.00 within 12 months, i.e. +24% vs the current price. The most bullish targets $84.00, the most cautious $65.00.
Note: analyst targets are 12-month (median $78.00, +24%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (34%), and the stock's past trajectory.
Its P/E is 59.4, forward P/E 31.1. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Cognex β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.